Research Topics
Genomes and Genes | M EstellerSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Epigenetics provides a new generation of oncogenes and tumour-suppressor genesM Esteller
Cancer Epigenetics Laboratory, 3rd Floor, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Br J Cancer 94:179-83. 2006....
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionSantiago Ropero
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, 28029 Madrid, Spain
Nat Genet 38:566-9. 2006..As such drugs may serve as therapeutic agents for cancer, our findings support the use of HDAC2 mutational status in future pharmacogenetic treatment of these individuals...
A microRNA DNA methylation signature for human cancer metastasisAmaia Lujambio
Cancer Epigenetics Laboratory, Spanish National Cancer Research Center, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Proc Natl Acad Sci U S A 105:13556-61. 2008..Our findings indicate that DNA methylation-associated silencing of tumor suppressor miRNAs contributes to the development of human cancer metastasis...
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylationGuro E Lind
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
Mol Cancer 4:8. 2005..However, other epigenetic mechanisms, such as modulation of chromatin structure or modifications of histones, may explain the lack of NKX3.1 expression, which is seen in most TGCTs and prostate cancer specimens...
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell linesGuro E Lind
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
Mol Cancer 3:28. 2004..We compared the DNA methylation profiles of the cell lines with those of the primary tumors. Finally, we examined if the epigenetic changes were associated with known genetic markers and/or clinicopathological variables...
Epigenetics in cancerManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Research Center, Madrid, Spain
N Engl J Med 358:1148-59. 2008
Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the icebergManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Center CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Clin Immunol 109:80-8. 2003..Furthermore, promising studies using DNA demethylating agents and histone deacetylase inhibitors are underway to awake these dormant tumor-suppressor genes for a better treatment of the patient with a hematologic malignancy...
Epigenetic gene silencing in cancer: the DNA hypermethylomeManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Hum Mol Genet 16:R50-9. 2007..In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells...
Aberrant DNA methylation as a cancer-inducing mechanismManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Center CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Annu Rev Pharmacol Toxicol 45:629-56. 2005..Finally, we must expect the development of new and more specific DNA demethylating agents that awake these methyl-dormant tumor suppressor genes and prove their therapeutic values. The expectations are high...
DNA methylation and cancer therapy: new developments and expectationsManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO Madrid, Spain
Curr Opin Oncol 17:55-60. 2005..These sites, among others, are the targets of DNA-demethylating agents, the promising chemotherapeutic drugs that are the focus of this article...
Dormant hypermethylated tumour suppressor genes: questions and answersManel Esteller
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
J Pathol 205:172-80. 2005....
The necessity of a human epigenome projectManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Carcinogenesis 27:1121-5. 2006..We need to make an ambitious step to understand the DNA methylation and histone changes underlying tumorigenesis. The launching of an International Human Epigenome Project should be the response to this necessity...
Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancerManel Esteller
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center CNIO, Melchor Fernandez Almagro 3, Madrid 28029, Spain
Oncogene 23:1-8. 2004..These recent results underscore the importance of MGMT in basic and translational cancer research...
How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyondManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
EMBO Rep 6:624-8. 2005
Cancer epigenomics: DNA methylomes and histone-modification mapsManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Nat Rev Genet 8:286-98. 2007..It is time to 'upgrade' cancer epigenetics research and put together an ambitious plan to tackle the many unanswered questions in this field using epigenomics approaches...
Relevance of DNA methylation in the management of cancerManel Esteller
Cancer Epigenetics Laboratory at the Spanish National Cancer Centre CNiO, Madrid, Spain
Lancet Oncol 4:351-8. 2003..Finally, dormant tumour suppressor genes can be reactivated by DNA demethylating drugs, with the aim of reversing the neoplastic phenotype. These are new avenues worth exploring in the fight against cancer...
Epigenetic control of nuclear architectureJ Espada
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029, Madrid, Spain
Cell Mol Life Sci 64:449-57. 2007..Here we briefly summarize present concepts of nuclear architecture and current data supporting a link between DNA methylation and the maintenance of large-scale nuclear organization...
Transforming pathways unleashed by a HDAC2 mutation in human cancerS Ropero
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Madrid, Spain
Oncogene 27:4008-12. 2008..These results suggest a role for HDAC2 mutations in human tumorigenesis through the derepression of key genes from multiple cellular transformation pathways...
Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cellsPedro P Medina
Lung Cancer Group, Molecular Pathology Programme, Spanish National Cancer Centre, C Melchior Fernandez Almagro 3, 28029 Madrid, Spain
Hum Mol Genet 14:973-82. 2005....
Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messengerEsteban Ballestar
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Biochem Cell Biol 83:374-84. 2005..The latter is a member of this family of proteins and appears to play a role in reducing mutations at 5-methylcytosine. This review examines the contribution of methyl-CpG-binding proteins in the epigenetic pathway of cancer...
Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteinsL Lopez-Serra
Cancer Epigenetics Laboratory, Spanish National Cancer Research Centre CNIO, Madrid, Spain
Oncogene 27:3556-66. 2008..Our data support a fundamental role for MBD proteins in the direct maintenance of transcriptional repression of tumor suppressors and identify new candidate genes for epigenetic disruption in cancer cells...
Epigenetic regulation of telomeres in human cancerE Vera
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Center CNIO, Madrid, Spain
Oncogene 27:6817-33. 2008..All together, these findings suggest that tumor telomere length and integrity can be influenced by the epigenetic status of cancer cells...
Mutator pathways unleashed by epigenetic silencing in human cancerFilipe V Jacinto
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
Mutagenesis 22:247-53. 2007....
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancerEsteban Ballestar
Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
EMBO J 22:6335-45. 2003..Our results support an essential role for MBDs in gene silencing and, when combined with genomic strategies, their potential to 'catch' new hypermethylated genes in cancer...
Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferasesMaria F Paz
Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Hum Mol Genet 12:2209-19. 2003..Thus, our results demonstrate the role of DNMT1 and DNMT3b in CpG island methylation associated silencing and the usefulness of genetic disruption strategies in searching for new hypermethylated loci...
DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targetsMichel Herranz
Cancer Epigenetic Laboratory, Molecular Pathology Program, Spanish National Cancer Centre, Madrid, Spain
Methods Mol Biol 361:25-62. 2007..Aberrant patterns of epigenetic modifications will be, in a near future, crucial parameters in cancer diagnosis and prognosis...
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancerO Aguilera
Instituto de Investigaciones Biomédicas Alberto Sols and Departamento de Bioquímica, Facultad de Medicina, Consejo Superior de Investigaciones Cientificas Universidad Autonoma de Madrid, Madrid, Spain
Oncogene 25:4116-21. 2006....
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastomaMiguel Alaminos
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
J Natl Cancer Inst 96:1208-19. 2004..Transcriptional silencing of tumor suppressor genes mediated by hypermethylation of promoter CpG islands is a hallmark of human tumors. We addressed the clinical relevance of promoter hypermethylation in neuroblastoma...
A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumorsMario F Fraga
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre, Madrid, Spain
Cancer Res 64:5527-34. 2004....
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cellsSantiago Ropero
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Hum Mol Genet 13:2753-65. 2004..These findings highlight the importance of EXT1 epigenetic inactivation, leading to an abrogation of HS biosynthesis, in the processes of tumor onset and progression...
The impact of chromatin in human cancer: linking DNA methylation to gene silencingEsteban Ballestar
Cancer Epigenetics Laboratory, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain
Carcinogenesis 23:1103-9. 2002..In this review we present the models of how repressor complexes may modify chromatin structure and mediate silencing of tumour suppressor and DNA repair genes...
Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomasA Sanchez
1Unidad de Biología Celular, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain
Oncogene 27:4969-72. 2008..Finally, we detected that hSpry2 promoter hypermethylation was associated with a significant decrease in the 5-year survival rate. These data suggest that hSpry2 could be important in lymphoid malignancies...
Proteins that bind methylated DNA and human cancer: reading the wrong wordsL Lopez-Serra
Cancer Epigenetics Group, Spanish National Cancer Research Centre CNIO, Melchor Fernandez Almagro 3, Madrid 28029, Spain
Br J Cancer 98:1881-5. 2008..The generation of novel aberrantly hypermethylated regions during cancer development and progression makes MBD proteins interesting targets for their biological and clinical implications...
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureManel Esteller
Cancer Epigenetics Laboratory, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain
Oncogene 21:5427-40. 2002..Basic and translational will both be needed in the near future to fully understand the mechanisms, roles and uses of CpG island hypermethylation in human cancer. The expectations are high...
CpG island hypermethylation of tumor suppressor microRNAs in human cancerAmaia Lujambio
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Cell Cycle 6:1455-9. 2007..In the coming years we will come to realize more fully the relevance of this expected encounter between two forces-epigenetics and microRNAs-that are currently at the forefront of biology...
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumorsMaria F Paz
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Research Center CNIO, 28029 Madrid, Spain
Cancer Res 62:4519-24. 2002..029). The existence of these associations may provide another example of the interplay between genetic and epigenetic factors in the cancer cell...
A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancerLidia Lopez-Serra
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Cancer Res 66:8342-6. 2006..Our results indicate that MBDs have a great affinity in vivo for binding hypermethylated promoter CpG islands of tumor suppressor genes, with a specific profile of MBD occupancy that it is gene and tumor type specific...
Histone deacetylase inhibitors: understanding a new wave of anticancer agentsAna Villar-Garea
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Int J Cancer 112:171-8. 2004..Our current data indicate that the use of HDAC inhibitors, probably in association with classical chemotherapy drugs or in combination with DNA-demethylating agents, could be promising for cancer patients...
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancerRuben Agrelo
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Proc Natl Acad Sci U S A 103:8822-7. 2006..These findings highlight the importance of WRN epigenetic inactivation in human cancer, leading to enhanced chromosomal instability and hypersensitivity to chemotherapeutic drugs...
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effectE Lara
Cancer Epigenetics Laboratory, Spanish National Cancer Research Centre CNIO, Madrid, Spain
Oncogene 28:781-91. 2009..Taken together, our results underline Salermide's promise as an anticancer drug and provide evidence for the molecular mechanism through which Sirt1 is involved in human tumorigenesis...
New therapeutic targets in cancer: the epigenetic connectionMichel Herranz
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre (CNIO, Madrid, Spain
Clin Transl Oncol 8:242-9. 2006..Aberrant patterns of epigenetic modifications will be, in a near future, crucial parameters in cancer diagnosis, prognosis and therapy...
The epigenetic breakdown of cancer cells: from DNA methylation to histone modificationsEsteban Ballestar
Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Prog Mol Subcell Biol 38:169-81. 2005..The identification of these connections has contributed not only to understanding how epigenetic deregulation occurs in cancer but also to developing novel therapies that can reverse epigenetic defects in cancer cells...
Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cellsJesus Espada
Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Madrid, Spain
Nucleic Acids Res 35:2191-8. 2007..These findings suggest a role for Dnmt1 as an epigenetic caretaker for the maintenance of nucleolar structure...
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerMario F Fraga
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Nat Genet 37:391-400. 2005..Our data suggest that the global loss of monoacetylation and trimethylation of histone H4 is a common hallmark of human tumor cells...
Cancer epigenetics: DNA methylation and chromatin alterations in human cancerManel Esteller
Cancer Epigenetics Laboratory, Spanish National Cancer Center (CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Adv Exp Med Biol 532:39-49. 2003..The eruption of new technologies for the careful study of the DNA methylation patterns, and their genetic partners in accomplishing gene silencing, it may also provide us with new drugs for the epigenetic treatment of human tumors...
Combinatorial effects of splice variants modulate function of AiolosRosalia Caballero
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
J Cell Sci 120:2619-30. 2007..These data support the general principle that the function of an individual protein is modulated through alternative splicing, and highlight a number of potential implications for Aiolos in normal and aberrant lymphocyte function...
Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification patternJesus Espada
Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
J Biol Chem 279:37175-84. 2004..Our data indicate that DNMT1 activity, via maintenance of the appropriate histone H3 modifications, contributes to the preservation of the correct organization of large heterochromatic regions...
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignanciesMario F Fraga
Cancer Epigenetics Laboratory, Spanish National Cancer Research Centre, Madrid, Spain
Cancer Res 68:4116-22. 2008..These data suggest that TLE1 epigenetic inactivation contributes to the development of hematologic malignancies by disrupting critical differentiation and growth-suppressing pathways...
MGMT hypermethylation: a prognostic foe, a predictive friendFilipe V Jacinto
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
DNA Repair (Amst) 6:1155-60. 2007..These findings underline the importance of MGMT promoter hypermethylation in basic and translational cancer research...
The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cellsOscar Aguilera
Instituto de Investigaciones Biomedicas Alberto Sols, Facultad de Medicina, Consejo Superior de Investigaciones Cientificas Universidad Autonoma de Madrid, Arturo Duperier, 4, 28029 Madrid, Spain
Carcinogenesis 28:1877-84. 2007..DKK-1 gene induction constitutes a novel mechanism of inhibition of Wnt signalling and antitumour action by 1,25(OH)2D3...
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding propertiesMario F Fraga
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center (CNIO, C/ Melchor Fernandez Almagro, No. 3, E-28029, Madrid, Spain
Nucleic Acids Res 31:1765-74. 2003..Interestingly, the binding affinity of specific MBD proteins for methylated DNA fragments from naturally occurring sequences are affected by local methyl-CpG spacing...
Epigenetic gene regulation in cancerEsteban Ballestar
Cancer Epigenetics Group, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, 28029 Madrid, Spain
Adv Genet 61:247-67. 2008..In addition, because epigenetic changes are reversible, enzymes involved in their maintenance stand as targets for a variety of compounds for therapy...
Quantification of global DNA methylation by capillary electrophoresis and mass spectrometryMaria Berdasco
Epigenetics Group, Molecular Pathology Program, Spanish National Cancer Center C N I O, Madrid, Spain
Methods Mol Biol 507:23-34. 2009....
Cross-talk between aging and cancer: the epigenetic languageMario F Fraga
Epigenetics Laboratory, Spanish National Cancer Centre CNIO, 28029 Madrid, Spain
Ann N Y Acad Sci 1100:60-74. 2007..We discuss the biological significance of both groups of epigenetic modifications in terms of their relative contribution to ontogenic development, senescence, and cell proliferation...
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 functionSonia A Melo
Cancer Epigenetics Laboratory, Spanish National Cancer Research Centre CNIO, 28029 Madrid, Spain
Nat Genet 41:365-70. 2009..Most important, the TRBP impairment is associated with a destabilization of the DICER1 protein. These results provide, for a subset of human tumors, an explanation for the observed defects in the expression of mature miRNAs...
The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNAIsabel Lopez de Silanes
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Research Centre CNIO, 28029 Madrid, Spain
Nucleic Acids Res 37:2658-71. 2009....
Aberrant regulation of messenger RNA 3'-untranslated region in human cancerIsabel Lopez de Silanes
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Cell Oncol 29:1-17. 2007..A thorough understanding of these alterations and their impact upon 3'UTR-directed posttranscriptional gene regulation will uncover promising new targets for therapeutic intervention...
Cancer genes hypermethylated in human embryonic stem cellsVincenzo Calvanese
Cancer Epigenetics Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain
PLoS ONE 3:e3294. 2008....
The epigenetic face of systemic lupus erythematosusEsteban Ballestar
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
J Immunol 176:7143-7. 2006..In the present study, we discuss the implications of epigenetic alterations in the development and progression of SLE and how epigenetic drugs constitute a promising source of therapy to treat this disease...
A systematic profile of DNA methylation in human cancer cell linesMaria F Paz
Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center, Carlos III Institute of Health, 28029 Madrid, Spain
Cancer Res 63:1114-21. 2003..Our data provide a basis for a better use of human cancer cell lines in basic and translational research with respect to their DNA methylation environment...
High-performance capillary electrophoretic method for the quantification of 5-methyl 2'-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissuesMario F Fraga
Laboratorio de Fisiologia Vegetal, Dpt B O S, Facultad de Biologia, Universidad de Oviedo, Oviedo, Spain
Electrophoresis 23:1677-81. 2002....
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutationsPaloma Fernandez
Lymphomas and Lung Cancer Laboratory, Spanish National Cancer Centre CNIO, Madrid, Spain
Oncogene 23:5084-91. 2004....
Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumorsPedro P Medina
Lymphoma and Lung Cancer Group, Molecular Pathology Program Spanish National Cancer Centre CNIO, Madrid, Spain
Genes Chromosomes Cancer 41:170-7. 2004..We cannot rule out that other mechanisms, such as complete or partial deletions of the SMARCA4 gene, are contributing to the loss of the SMARCA4 protein in lung cancer...
CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomasMaria F Paz
Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain
Clin Cancer Res 10:4933-8. 2004..These results may open up possibilities for more customized treatments of human brain tumors...
CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancerManuel Irimia
Molecular Pathology Program, Cancer Epigenetics Laboratory, Spanish National Cancer Centre CNIO, Melchor Fernandez Almagro 3, Madrid 28029, Spain
Oncogene 23:8695-9. 2004..008, Fisher's exact test). Thus, the mutual exclusivity of the epigenetic and genetic alterations in the two genes of the Ras pathway suggests that they play a critical and cooperative role in human tumorigenesis...
Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factorsMargarita Sanchez-Beato
Molecular Pathology Programme, Centro Nacional de Investigaciones Oncologicas CNIO, C Melchor Fernandez Almagro 3, E 28029 Madrid, Spain
J Pathol 204:528-37. 2004..These results allow us to propose that the formation of transcription complexes with E2F6 may modify the functional status of PcG proteins in HSR cells...
The impact of MECP2 mutations in the expression patterns of Rett syndrome patientsEsteban Ballestar
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre, , 28029 Madrid, Spain
Hum Genet 116:91-104. 2005..Our results provide new data of the underlying mechanisms of RTT and unveil novel targets of MeCP2-mediated gene repression...
A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylationSara Alvarez
Human Genetics Department, Molecular Pathology Programme, Spanish National Cancer Centre, c o Melchor Fernandez Almagro, 28029 Madrid, Spain
Clin Cancer Res 11:1146-53. 2005..This fact suggests that somatic BRCA1 inactivation could modify the profile of tumor progression in most of the BRCAX cases...
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastomaMiguel Alaminos
Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre, Madrid, Spain
Cancer Res 65:2565-71. 2005..03) and death of disease (Kendall tau, P = 0.03; r = 0.19). Thus, EMP3 is a good candidate for being the long-sought tumor suppressor gene located at 19q13 in gliomas and neuroblastomas...
DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemiaSara Alvarez
Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas, Centro de Investigaciones de Enfermedades Raras, Madrid, Spain
PLoS ONE 5:e12197. 2010..However, further studies to discuss the prognostic value and the relationship of the epigenetic signatures with defined genomic rearrangements in acute myeloid leukemia are required...
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancerAna Osorio
Department of Human Genetics, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
Int J Cancer 99:305-9. 2002....
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instabilityDavid Sarrio
Laboratory of Breast and Gynecological Cancer, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
Int J Cancer 106:208-15. 2003..The same tumors also show genetic and epigenetic alterations of APC gene. However, altered CDH1 and APC genes do not promote beta-catenin accumulation in this tumor type...
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lungMontserrat Sanchez-Cespedes
Department of Otolaryngology Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 2196, USA
Cancer Res 62:3659-62. 2002..Thus, our findings demonstrate for the first time that LKB1/STK11 inactivation is a very common event and may be integrally involved in the development of sporadic lung adenocarcinoma...
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarraysA Aleman
Tumor Markers Group, Molecular Pathology Program, Spanish National Cancer Center, Madrid, Spain
Br J Cancer 98:466-73. 2008..The association of SOX9 hypermethylation with tumour progression and clinical outcome suggests its relevant clinical implications at stratifying patients affected with bladder cancer...
Genetic and epigenetic profile of sporadic pheochromocytomasA Cascon
Hereditary Endocrine Cancer Group, Department of Human Genetics, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
J Med Genet 41:e30. 2004
Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancersWilliam A Palmisano
Lovelace Respiratory Research Institute, Lung Cancer Program, 2425 Ridgecrest Avenue S.E, Albuquerque, New Mexico 87108, USA
Cancer Res 63:4620-5. 2003..Recent studies have demonstrated the importance of PAX5 gene alterations in human cancer. Our results are the first to identify aberrant promoter methylation as a common mechanism for dysregulation of these genes in solid tumors...
The Polycomb group protein EZH2 directly controls DNA methylationEmmanuelle Viré
Free University of Brussels, Faculty of Medicine, Laboratory of Molecular Virology, 808 Route de Lennik, 1070 Brussels, Belgium
Nature 439:871-4. 2006..Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems...
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studiesWilliam M Gallagher
Department of Pharmacology, University College Dublin, Ireland
Carcinogenesis 26:1856-67. 2005..Overall, our data support the hypothesis that multiple genes are targeted, either directly or indirectly, by DNA hypermethylation during melanoma progression...
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasiaDavide Rossi
Hematology Unit, Dept. of Medical Sciences and IRCAD, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Haematologica 89:154-64. 2004..Finally, the frequency of GSTP1 aberrant methylation in diffuse large B-cell lymphoma prompts studies aimed at verifying the prognostic impact of this epigenetic lesion in these lymphomas...
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human CancerManel Esteller
The Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer Res 62:5902-5. 2002..Epigenetic disruption of CRBP1 is a common event in human cancer that may have important implications for cancer prevention and treatment using retinoids...
CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomasFrederic Tort
Laboratory of Pathology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Spain
Blood 100:4602-8. 2002..The high number of chromosomal imbalances in tumors with complete absence of CHK2 protein suggests a role of this gene in chromosomal instability in human lymphomas...
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myelomaOliver Galm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA
Blood 101:2784-8. 2003..Silencing of the SOCS-1 gene may impair negative regulation of the Jak/STAT pathway and therefore result in greater responsiveness to cytokines, thus supporting survival and expansion of MM cells...
Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancerSonia Mulero-Navarro
Cancer Epigenetics and Biology Program PEBC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Barcelona, Catalonia, Spain
Epigenetics 3:210-5. 2008..These results underpin the epigenetic inactivation of the chromating remodeling factor CHD5 as one contributor for the aberrant structural changes of chromatin throughout the genome of the cancer cell...
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphomaManel Esteller
Division of Cancer Biology, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA
J Natl Cancer Inst 94:26-32. 2002..CONCLUSION: MGMT promoter hypermethylation appears to be a useful marker for predicting survival in patients with B-DLCL treated with multidrug regimens including cyclophosphamide...
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancerYoshimitsu Akiyama
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
Mol Cell Biol 23:8429-39. 2003..Selection for silencing of both upstream transcription factors and their target genes in GI cancers could indicate that epigenetic silencing of the involved genes provides a summated contribution to tumor progression...
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumorsWen Yong Chen
Division of Tumor Biology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 1650 Orleans Street, Baltimore, Maryland 21231, USA
Nat Genet 33:197-202. 2003..We conclude that HIC1 is a candidate tumor-suppressor gene for which loss of function in both mouse and human cancers is associated only with epigenetic modifications...
Epigenetic biomarkers for human cancer: the time is nowSonia Mulero-Navarro
Cancer Epigenetics and Biology Program PEBC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avinguda Gran Via s n Km 2 7, E 08907 L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
Crit Rev Oncol Hematol 68:1-11. 2008....
